SCHEMBL19593798

SCHEMBL19593798

CC(=O)c1cccc(C2CN(C)Cc3c(Cl)cc(Cl)cc32)c1

nearest known ligand 0.65

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SLC9A3 P48764 15/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4029207 0.91 SLC9A3 (0.65) SLC9A3
SCHEMBL5751608 0.90 SLC9A3 (0.64) SLC9A3
SCHEMBL4025620 0.90 SLC9A3 (0.67) SLC9A3
SCHEMBL13467104 0.88 SLC9A3 (0.61) SLC9A3
SCHEMBL13449759 0.88 SLC9A3 (0.61) SLC9A3
SCHEMBL13449761 0.88 SLC9A3 (0.61) SLC9A3
SCHEMBL19593433 0.87 SLC9A3 (0.56) SLC9A3
SCHEMBL4025508 0.86 SLC9A3 (0.68) SLC9A3
SCHEMBL4034180 0.85 SLC9A3 (0.58) SLC9A3
SCHEMBL31314205 0.84 SLC9A3 (0.71) SLC9A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2384318-B1 COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS ARDELYX INC (US) 2017-11-15 EP disclosed